SU950388A1

SU950388A1 - Pulmonary tuberculosis patients treatment method

Info

Publication number: SU950388A1
Application number: SU782710713A
Authority: SU
Inventors: Эдуард Петрович Цыбань
Original assignee: За витель .::r« Mi ;V; г j 15 лЧ|)Г:5п.. ,. , f Iw Tjiv,,,; -И viy,. / : fi JkiiOViiK,-I
Priority date: 1978-11-04
Filing date: 1978-11-04
Publication date: 1982-08-15

Description

(5) СПОСОБ ЛЕЧЕНИЯ БОЛЬНЫХ ТУБЕРКУЛЕЗОМ ЛЕГКИХ(5) METHOD FOR TREATING PATIENTS WITH PULMONARY TUBERCULOSIS

1one

Изобретение относитс к медицине, а именно к фтизиатрии.This invention relates to medicine, namely phthisiology.

Известен способ лечени больных туберкулезом легких путем внутримышечного введени противотуберкулезных препаратов l.There is a method of treating patients with pulmonary tuberculosis by intramuscular administration of anti-tuberculosis drugs l.

Однако известный способ не позвол ет в большом числе случаев ликвидировать длительно незаживающие каверны легкого, вследствие чего низка его эффективность.However, the known method does not allow, in a large number of cases, to eliminate the long-term unhealed cavities of the lung, as a result of which its effectiveness is low.

Целью изобретени вл етс повышение эффективности лечени The aim of the invention is to increase the effectiveness of treatment

Поставленна цель достигаетс тем, что согласно способу лечени больных туберкулезом легких путем внутримышечного введени противотуберкулезных препаратов, препараты ввод т в межреберную мускулатуру у основани наиболее пораженного бронхолегочного сегмента.The goal is achieved by the fact that according to the method of treating patients with pulmonary tuberculosis by intramuscular administration of anti-tuberculosis drugs, the drugs are injected into the intercostal muscles at the base of the most affected bronchopulmonary segment.

Способ осуществл ют следующим образом .The method is carried out as follows.

Определ ющими ориентирами дл выбора места инъекции вл ютс обнаруживаемые на рентгенограммах и особенно на томограммах плевральные наслоени и плевролегочные т жи, спаивающие максимально пораженный сегмент легкого с м гкими ткан ми грудной стенки.The defining reference points for the choice of the injection site are the pleural layers and pleuropulmonary fusion found on radiographs and especially on tomograms, sucking the most affected lung segment with the soft tissues of the chest wall.

Прокол осуществл ют по верхнему краю ребра. Принима so внимание срав10 нительно небольшую толщину Лежреберной мускулатуры, максимальный объем вводимого pactвора не должен превышать 6,0-10,0 мл. Инъекции провод т ежедневно или через день.The puncture is carried out at the upper edge of the rib. Taking into account the comparatively small thickness of the Léschera musculature, the maximum volume of injected pact should not exceed 6.0-10.0 ml. Injections are given daily or every other day.

1515

Продолжительность курса лечени определ етс динамикой инволюции специфического процесса.The duration of the course of treatment is determined by the dynamics of the involution of a specific process.

Claims

The treatment by the proposed method is shown in 20 all-sick active, mainly local, pulmonary tuberculosis, especially in the presence of lung tissue breakdown. There are no contraindications for the proposed treatment. Example. Extract from the medical history of the patient F., 29 years old. Sent to inpatient treatment Odessa Oblast TB Dispensary. Pulmonary tuberculosis is detected during the passage of a medical commission at a military registration and enlistment office. Based on the clinical and radiological examination in stationary conditions, disseminated pulmonary tuberculosis IK {IK phase of infiltration and disintegration of BK + was diagnosed. The patient received 8 different perisses in the optimal dosage, in the form of strepto-injections. Mitsin per year (1.0 g every day) and ingested tubaned (0.6 g daily), benemycin (0.6 g daily, PAS (12.0 g daily, protionamtsd (0.75 g daily. Tuberculosis the treatment was carried out against the background of the widespread use of vitamins, desensitizing and stimulating drugs (CaC, pipolfen, placenta extract, aloe extract, plasmol, serum f). After 2 months, the cavities in both lungs ceased to be determined: the left in the place of the disintegration cavity - focal shadows and coarse complex specific pa togenetic treatment continued. However, after 6 months of hospital stay, a cavity opened in the right lung, taking into account the exacerbation of the tuberculous process. At 8 months of inpatient treatment, targeted intercostal intramuscular injection of 6.0 ml of a 10% solution of tubaside was applied (0, 6 g daily.) Except Saturday and Sunday. After 2 months, a control tomographic examination established healing of the cavity with the formation of minimal residual changes in the form of a small focal group. The patient is listed in t bsanatory achieved for securing therapeutic result. The application of the proposed method of treating pulmonary tuberculosis increases the effectiveness of treating these patients, shortens the length of stay in the hospital, and in a number of cases prevents surgical intervention. Claims of Invention A method of treating patients with pulmonary tuberculosis by intramuscular administration of anti-tuberculosis drugs, characterized in that, in order to increase the effectiveness of treatment, the drugs are injected into the intercostal muscles at the base of the most affected bronchopulmonary segment. Sources of information taken into account in the examination 1. Practical doctor's guide. Ed. Egorova PM and others. Part 1, ed. US, M., Medgiz, 1959 (prototype).